Please use this identifier to cite or link to this item:
|Title:||Patterns of prostate-specific antigen testing by remoteness of residence and socio-economic status: An Australian population-based study||Authors:||Calopedos, Ross J S ;Ruthven, Stephen ;Bang, A.;Baade, P.D.;Yu, X.Q.;Patel, M.I.;Smith, D.P.||Affliation:||Central Coast Local Health District
|Issue Date:||Jun-2019||Source:||27(3):216-223||Journal title:||The Australian Journal of Rural Health||Department:||Central Coast Cancer Centre
|Abstract:||OBJECTIVE: Describes the variation in prostate cancer testing by the remoteness of residence and socio-economic status groups in Australia. DESIGN: A national population-based descriptive study using Medicare data extracted by the Department of Health (formerly the Department of Health and Ageing). SETTING: Australia. PARTICIPANTS: All men, with a Medicare-reimbursed prostate-specific antigen test conducted in Australia between 2002 and 2017, were included. We focused on "screening and case finding" tests (Medicare Benefits Schedule item number 66655) from 1 April 2005 to 31 December 2009, to describe testing differences in subgroups. Groups were categorised into State and Territory, socio-economic status and region of residence. A negative binomial regression model was fitted to measure the incidence rate ratios of those who had a screening prostate-specific antigen test by group. MAIN OUTCOME MEASURES: Age-standardised testing rates and incidence rate ratios. RESULTS: Between 2002 and 2017, 11 588 775 screening prostate-specific antigen tests were reimbursed by the Department of Human Services. During 2005-2009, 52% of all Australian men, aged 40 years and over, had a screening test. The incidence rate ratios differed by State and Territory. Men aged 40 years and over, living in very remote areas, were 43% less likely to have had a screening test than residents of major cities. Prostate-specific antigen testing rates fell in all age groups between 2007 and 2009 and 2017. CONCLUSIONS: The prostate-specific antigen testing behaviour differs between community groups in Australia. Men were less likely to have had a screening prostate-specific antigen test the farther they lived from the major cities. This highlights the need for a more targeted approach to achieve an equitable and evidence-based prostate cancer care across all sectors of the community.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1478||DOI:||10.1111/ajr.12504||Pubmed:||https://www.ncbi.nlm.nih.gov/pubmed/31070837||ISSN:||1038-5282||Publicaton type:||Journal Article|
|Appears in Collections:||Health Service Research|
Show full item record
checked on Jan 31, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.